Whereas TLR9 agonists are recognized as powerful stimulators of antitumor immunity, GM-CSF has had mixed reviews. In previously reported randomized trials we assessed the effects of local immune modulation in early-stage melanoma with CpG-B alone or with GM-CSF. Here we discuss the added value of GM-CSF and show sex-related differences.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6959435 | PMC |
| http://dx.doi.org/10.1080/2162402X.2019.1708066 | DOI Listing |
Publication Analysis
Top Keywords
early-stage melanoma
8
mix potential
4
potential benefits
4
benefits adding
4
gm-csf
4
adding gm-csf
4
gm-csf cpg-b
4
cpg-b local
4
local treatment
4
treatment patients
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!